Professor of Biomedical Engineering, Johns Hopkins University
I did the first experiments showing altered DNA methylation in cancer. I showed that epigenetic changes (chemical changes other than DNA sequence per se) cause cancer are not simply consequential to it through my studies of the disorder Beckwith-Wiedemann syndrome. Later I had the first NIH funded epigenome center. More recently I have developed the idea the genetic variants can control epigenetic stochasticity (plasticity) and phenotype (traits) under evolutionary selection in natural populations, or within an individual in the development of cancer.
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Biden administration tells employers to stop shackling workers with ‘noncompete agreements’
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects